BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 23277357)

  • 1. Distinct phosphotyrosine-dependent functions of the ShcA adaptor protein are required for transforming growth factor β (TGFβ)-induced breast cancer cell migration, invasion, and metastasis.
    Northey JJ; Dong Z; Ngan E; Kaplan A; Hardy WR; Pawson T; Siegel PM
    J Biol Chem; 2013 Feb; 288(7):5210-22. PubMed ID: 23277357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signaling through ShcA is required for transforming growth factor beta- and Neu/ErbB-2-induced breast cancer cell motility and invasion.
    Northey JJ; Chmielecki J; Ngan E; Russo C; Annis MG; Muller WJ; Siegel PM
    Mol Cell Biol; 2008 May; 28(10):3162-76. PubMed ID: 18332126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The SHCA adapter protein cooperates with lipoma-preferred partner in the regulation of adhesion dynamics and invadopodia formation.
    Kiepas A; Voorand E; Senecal J; Ahn R; Annis MG; Jacquet K; Tali G; Bisson N; Ursini-Siegel J; Siegel PM; Brown CM
    J Biol Chem; 2020 Jul; 295(31):10535-10559. PubMed ID: 32299913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ShcA SH2 domain engages a 14-3-3/PI3'K signaling complex and promotes breast cancer cell survival.
    Ursini-Siegel J; Hardy WR; Zheng Y; Ling C; Zuo D; Zhang C; Podmore L; Pawson T; Muller WJ
    Oncogene; 2012 Nov; 31(48):5038-44. PubMed ID: 22286768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ShcA signalling is essential for tumour progression in mouse models of human breast cancer.
    Ursini-Siegel J; Hardy WR; Zuo D; Lam SH; Sanguin-Gendreau V; Cardiff RD; Pawson T; Muller WJ
    EMBO J; 2008 Mar; 27(6):910-20. PubMed ID: 18273058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integration of Distinct ShcA Signaling Complexes Promotes Breast Tumor Growth and Tyrosine Kinase Inhibitor Resistance.
    Ha JR; Ahn R; Smith HW; Sabourin V; Hébert S; Cepeda Cañedo E; Im YK; Kleinman CL; Muller WJ; Ursini-Siegel J
    Mol Cancer Res; 2018 May; 16(5):894-908. PubMed ID: 29453318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential utilization of ShcA tyrosine residues and functional domains in the transduction of epidermal growth factor-induced mitogen-activated protein kinase activation in 293T cells and nerve growth factor-induced neurite outgrowth in PC12 cells. Identification of a new Grb2.Sos1 binding site.
    Thomas D; Bradshaw RA
    J Biol Chem; 1997 Aug; 272(35):22293-9. PubMed ID: 9268379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Grb2 and Shc adapter proteins play distinct roles in Neu (ErbB-2)-induced mammary tumorigenesis: implications for human breast cancer.
    Dankort D; Maslikowski B; Warner N; Kanno N; Kim H; Wang Z; Moran MF; Oshima RG; Cardiff RD; Muller WJ
    Mol Cell Biol; 2001 Mar; 21(5):1540-51. PubMed ID: 11238891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ShcA adaptor activates AKT signaling to potentiate breast tumor angiogenesis by stimulating VEGF mRNA translation in a 4E-BP-dependent manner.
    Im YK; La Selva R; Gandin V; Ha JR; Sabourin V; Sonenberg N; Pawson T; Topisirovic I; Ursini-Siegel J
    Oncogene; 2015 Mar; 34(13):1729-35. PubMed ID: 24837366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ShcA PTB domain functions as a biological sensor of phosphotyrosine signaling during breast cancer progression.
    Ahn R; Sabourin V; Ha JR; Cory S; Maric G; Im YK; Hardy WR; Zhao H; Park M; Hallett M; Siegel PM; Pawson T; Ursini-Siegel J
    Cancer Res; 2013 Jul; 73(14):4521-32. PubMed ID: 23695548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A mammalian adaptor protein with conserved Src homology 2 and phosphotyrosine-binding domains is related to Shc and is specifically expressed in the brain.
    O'Bryan JP; Songyang Z; Cantley L; Der CJ; Pawson T
    Proc Natl Acad Sci U S A; 1996 Apr; 93(7):2729-34. PubMed ID: 8610109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adaptor ShcA protein binds tyrosine kinase Tie2 receptor and regulates migration and sprouting but not survival of endothelial cells.
    Audero E; Cascone I; Maniero F; Napione L; Arese M; Lanfrancone L; Bussolino F
    J Biol Chem; 2004 Mar; 279(13):13224-33. PubMed ID: 14665640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-redundant role of Shc in Erk activation by cytoskeletal reorganization.
    Faisal A; Kleiner S; Nagamine Y
    J Biol Chem; 2004 Jan; 279(5):3202-11. PubMed ID: 14576154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutant p53 disrupts role of ShcA protein in balancing Smad protein-dependent and -independent signaling activity of transforming growth factor-β (TGF-β).
    Lin S; Yu L; Yang J; Liu Z; Karia B; Bishop AJR; Jackson J; Lozano G; Copland JA; Mu X; Sun B; Sun LZ
    J Biol Chem; 2011 Dec; 286(51):44023-44034. PubMed ID: 22039050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ShcA phosphotyrosine docking protein uses distinct mechanisms to regulate myocyte and global heart function.
    Vanderlaan RD; Hardy WR; Kabir MG; Pasculescu A; Jones N; deTombe PP; Backx PH; Pawson T
    Circ Res; 2011 Jan; 108(2):184-93. PubMed ID: 21148430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ShcA and Grb2 mediate polyoma middle T antigen-induced endothelial transformation and Gab1 tyrosine phosphorylation.
    Ong SH; Dilworth S; Hauck-Schmalenberger I; Pawson T; Kiefer F
    EMBO J; 2001 Nov; 20(22):6327-36. PubMed ID: 11707404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interplay between ShcA Signaling and PGC-1α Triggers Targetable Metabolic Vulnerabilities in Breast Cancer.
    Im YK; Najyb O; Gravel SP; McGuirk S; Ahn R; Avizonis DZ; Chénard V; Sabourin V; Hudson J; Pawson T; Topisirovic I; Pollak M; St-Pierre J; Ursini-Siegel J
    Cancer Res; 2018 Sep; 78(17):4826-4838. PubMed ID: 29930100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ShcA adaptor protein is a critical regulator of breast cancer progression.
    Ursini-Siegel J; Muller WJ
    Cell Cycle; 2008 Jul; 7(13):1936-43. PubMed ID: 18604176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discrimination between phosphotyrosine-mediated signaling properties of conventional and neuronal Shc adapter molecules.
    Nakamura T; Komiya M; Gotoh N; Koizumi S; Shibuya M; Mori N
    Oncogene; 2002 Jan; 21(1):22-31. PubMed ID: 11791173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ShcA Protects against Epithelial-Mesenchymal Transition through Compartmentalized Inhibition of TGF-β-Induced Smad Activation.
    Muthusamy BP; Budi EH; Katsuno Y; Lee MK; Smith SM; Mirza AM; Akhurst RJ; Derynck R
    PLoS Biol; 2015 Dec; 13(12):e1002325. PubMed ID: 26680585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.